You’re in the middle of a Q-bank set, you see “hypoketotic hypoglycemia,” and your brain immediately goes: “beta-oxidation.” That’s the right instinct—but Step questions love punishing anyone who stops there. The real points come from (1) knowing why the correct answer is correct and (2) being able to prove every distractor is wrong using one or two high-yield facts.
Tag: Biochemistry > Lipid Metabolism
The Clinical Vignette
A 9-month-old infant is brought to the ED for lethargy and vomiting after a viral illness. The parents report poor oral intake for ~18 hours. Exam shows mild hepatomegaly. Labs:
- Glucose: low
- Serum ketones: low
- AST/ALT: mildly elevated
- Ammonia: elevated
- Acylcarnitine profile: elevated medium-chain acylcarnitines (C6–C10)
Which enzyme is most likely deficient?
A. Carnitine palmitoyltransferase I (CPT I)
B. Carnitine palmitoyltransferase II (CPT II)
C. Medium-chain acyl-CoA dehydrogenase (MCAD)
D. Glucose-6-phosphatase
E. Very-long-chain acyl-CoA dehydrogenase (VLCAD)
F. HMG-CoA lyase
Stepwise Approach: What the Stem Is Screaming
1) The pattern: hypoketotic hypoglycemia
During fasting/illness, the liver should:
- Break down fatty acids via beta-oxidation → generate acetyl-CoA + NADH + FADH2
- Use acetyl-CoA to drive ketogenesis
- Use beta-oxidation energy to support gluconeogenesis
If beta-oxidation fails → you lose both:
- Ketones (low acetyl-CoA for ketogenesis)
- Glucose (gluconeogenesis stalls because it’s energy-hungry and acetyl-CoA normally activates pyruvate carboxylase)
This combo is the classic USMLE fingerprint of a fatty acid oxidation disorder.
2) The acylcarnitine clue
- Elevated C6–C10 acylcarnitines = medium-chain species accumulating
- That points directly to MCAD deficiency
Correct Answer: C. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency
Why it’s correct
MCAD catalyzes the first dehydrogenation step in beta-oxidation for medium-chain fatty acids. When it’s deficient:
- Medium-chain fatty acids can’t be oxidized efficiently
- Medium-chain acylcarnitines rise (because acyl groups get shunted onto carnitine)
- The patient can’t generate enough:
- ATP for gluconeogenesis
- Acetyl-CoA for ketogenesis
Classic clinical picture (high-yield)
- Infant/child with illness or fasting trigger
- Vomiting, lethargy, seizures
- Hypoketotic hypoglycemia
- Can have sudden death
- Often abnormal newborn screen (acylcarnitine profile)
High-yield management
- Avoid fasting
- Frequent feeds
- Give glucose during illness
- Some sources also emphasize carnitine supplementation in select cases (management can vary; test-day core is “avoid fasting + give glucose”)
Beta-Oxidation in One Table (Because You’ll Be Asked)
| Concept | High-yield takeaway |
|---|---|
| Where beta-oxidation happens | Mitochondrial matrix (very-long chains start in peroxisomes) |
| What beta-oxidation produces | Acetyl-CoA, NADH, FADH2 |
| Why fasting needs beta-oxidation | Powers gluconeogenesis + provides acetyl-CoA for ketones |
| “Hypoketotic hypoglycemia” implies | Fatty acid oxidation defect |
| Newborn screen clue | Acylcarnitine profile identifies chain-length pattern |
Now Destroy the Distractors (This Is Where the Points Live)
A. Carnitine palmitoyltransferase I (CPT I) deficiency
Why it’s tempting: It’s a fatty acid oxidation issue and can cause fasting intolerance.
Why it’s wrong here:
- CPT I is on the outer mitochondrial membrane and is needed to shuttle long-chain fatty acids into mitochondria.
- With CPT I deficiency, you can’t form acylcarnitines effectively → you’d expect low long-chain acylcarnitines, not a classic medium-chain (C6–C10) elevation.
High-yield pearl:
CPT I deficiency → decreased fatty acid entry → hypoketotic hypoglycemia, but the acylcarnitine pattern differs from MCAD.
B. Carnitine palmitoyltransferase II (CPT II) deficiency
Why it’s tempting: Another carnitine shuttle enzyme; Step loves CPT I vs CPT II.
Why it’s wrong here:
- CPT II is on the inner mitochondrial membrane (matrix side) and defects classically hit muscle.
- Typical presentation: recurrent myoglobinuria and muscle pain after prolonged exercise/fasting (esp. adolescent/adult forms).
- The stem is an infant with medium-chain acylcarnitines, which is much more MCAD.
High-yield pearl:
CPT II deficiency = muscle symptoms + myoglobinuria >> isolated hypoglycemia vignette.
D. Glucose-6-phosphatase deficiency (Von Gierke, Glycogen storage disease type I)
Why it’s tempting: Hypoglycemia + hepatomegaly.
Why it’s wrong here: Von Gierke is a glycogenolysis/gluconeogenesis output problem, not beta-oxidation. Key distinguishing features:
- Lactic acidosis (big one)
- Hyperuricemia, hypertriglyceridemia
- Ketones are not characteristically low due to impaired beta-oxidation; ketogenesis can still occur because fatty acid oxidation machinery is intact.
High-yield pearl:
If you see hypoglycemia + lactic acidosis + hepatomegaly → think Von Gierke, not MCAD.
E. Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency
Why it’s tempting: Same enzyme family as MCAD; same basic pathway.
Why it’s wrong here:
- VLCAD affects very-long-chain fatty acids.
- Newborn screening tends to show elevated very-long-chain acylcarnitines (e.g., C14:1 is commonly cited), not medium-chain (C6–C10).
- Clinical can include cardiomyopathy or severe neonatal disease depending on phenotype.
High-yield pearl:
Chain-length matters: MCAD → medium-chain pattern; VLCAD → very-long-chain pattern and often more cardiac involvement.
F. HMG-CoA lyase deficiency
Why it’s tempting: It’s tied to ketone body formation → could cause low ketones.
Why it’s wrong here:
- HMG-CoA lyase is required for ketogenesis (and leucine catabolism).
- A ketogenesis defect causes hypoketotic hypoglycemia, yes—but the stem gives an acylcarnitine pattern pointing to beta-oxidation (C6–C10 elevation).
- Also, primary ketogenesis defects don’t classically produce the hallmark fatty-acid oxidation acylcarnitine signature.
High-yield pearl:
Beta-oxidation defects often show abnormal acylcarnitines; isolated ketogenesis defects won’t give the same chain-length acylcarnitine buildup.
The 10-Second Test-Day Rule Set
When you see hypoketotic hypoglycemia, ask:
- Fasting/illness trigger?
- Acylcarnitine profile?
- C6–C10 elevated → MCAD
- Very-long-chain elevated → VLCAD
- Muscle symptoms/myoglobinuria?
- Yes → consider CPT II
- Lactic acidosis + hyperuricemia + big hepatomegaly?
- Yes → consider Von Gierke
Mini Rapid-Fire: High-Yield Facts You’ll Actually Use
- Beta-oxidation supplies energy for gluconeogenesis; when it fails → hypoglycemia.
- Acetyl-CoA is necessary for ketones; when beta-oxidation fails → hypoketosis.
- MCAD deficiency: episodic vomiting/lethargy after fasting, C6–C10 acylcarnitines, risk of sudden death.
- Treat fatty acid oxidation disorders acutely with glucose; chronically with avoidance of fasting.